NO961429L - Fremgangsmåte for fremstilling av kinolonholdige, orale preparater - Google Patents

Fremgangsmåte for fremstilling av kinolonholdige, orale preparater

Info

Publication number
NO961429L
NO961429L NO961429A NO961429A NO961429L NO 961429 L NO961429 L NO 961429L NO 961429 A NO961429 A NO 961429A NO 961429 A NO961429 A NO 961429A NO 961429 L NO961429 L NO 961429L
Authority
NO
Norway
Prior art keywords
quinolone
preparation
oral preparations
containing oral
introducing
Prior art date
Application number
NO961429A
Other languages
English (en)
Other versions
NO961429D0 (no
Inventor
Gabriel Gousset
Philippe Riviere
Original Assignee
Rhone Dpc Europ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Dpc Europ filed Critical Rhone Dpc Europ
Publication of NO961429D0 publication Critical patent/NO961429D0/no
Publication of NO961429L publication Critical patent/NO961429L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En forbedret, oral formulering av aktive bestanddeler fra kinolonklassen oppnås ved en fremgangsmåte som omfatter innføring av et kompakteringstrinn med efterfølgende oppmaling før den egentlige kompresjon av blandingen av aktiv bestanddel og drøyemidler.
NO961429A 1993-10-21 1996-04-11 Fremgangsmåte for fremstilling av kinolonholdige, orale preparater NO961429L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9312550A FR2711524B1 (fr) 1993-10-21 1993-10-21 Procédé de préparation de compositions orales contenant des quinolones.
PCT/FR1994/001212 WO1995011023A1 (fr) 1993-10-21 1994-10-19 Procede de preparation de compositions orales contenant des quinolones

Publications (2)

Publication Number Publication Date
NO961429D0 NO961429D0 (no) 1996-04-11
NO961429L true NO961429L (no) 1996-04-11

Family

ID=9452072

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961429A NO961429L (no) 1993-10-21 1996-04-11 Fremgangsmåte for fremstilling av kinolonholdige, orale preparater

Country Status (29)

Country Link
US (1) US5840333A (no)
EP (1) EP0724442A1 (no)
AT (1) ATA905894A (no)
AU (1) AU7997094A (no)
BE (1) BE1007326A3 (no)
CA (1) CA2174444A1 (no)
CH (1) CH686555A5 (no)
CO (1) CO4180603A1 (no)
CZ (1) CZ113696A3 (no)
DZ (1) DZ1818A1 (no)
EE (1) EE9600050A (no)
ES (1) ES2126474B1 (no)
FI (1) FI961717A0 (no)
FR (1) FR2711524B1 (no)
GB (1) GB2297908B (no)
GR (1) GR1002181B (no)
HU (1) HUT74181A (no)
IE (1) IE940838A1 (no)
IT (1) IT1270672B (no)
MA (1) MA23331A1 (no)
NO (1) NO961429L (no)
NZ (1) NZ274874A (no)
OA (1) OA10282A (no)
PL (1) PL314005A1 (no)
SG (1) SG52202A1 (no)
SK (1) SK50596A3 (no)
TN (1) TNSN94110A1 (no)
WO (2) WO1995011023A1 (no)
ZA (1) ZA948175B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177101B1 (en) * 1998-06-11 2001-01-23 Pharmacia & Upjohn Company Delavirdine high strength tablet formulation
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
CN102499928A (zh) 2004-08-13 2012-06-20 先灵-普劳有限公司 包含抗菌素、三唑和皮质类固醇的药物制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
US4973470A (en) * 1989-06-26 1990-11-27 Warner-Lambert Company Sustained release pharmaceutical compositions
JPH10175936A (ja) * 1996-12-17 1998-06-30 Kao Corp 新規アミドアミノポリカルボン酸又はその塩、及びそれを含有する洗浄剤組成物

Also Published As

Publication number Publication date
OA10282A (fr) 1997-10-07
GB9608316D0 (en) 1996-06-26
WO1995011023A1 (fr) 1995-04-27
HUT74181A (en) 1996-11-28
ZA948175B (en) 1995-06-08
NZ274874A (en) 1997-10-24
GB2297908B (en) 1997-12-10
US5840333A (en) 1998-11-24
FI961717A (fi) 1996-04-19
ES2126474B1 (es) 1999-11-16
FI961717A0 (fi) 1996-04-19
DZ1818A1 (fr) 2002-02-17
EP0724442A1 (fr) 1996-08-07
FR2711524B1 (fr) 1995-11-24
ES2126474A1 (es) 1999-03-16
CZ113696A3 (en) 1996-07-17
GB2297908A (en) 1996-08-21
SK50596A3 (en) 1997-02-05
FR2711524A1 (fr) 1995-05-05
CO4180603A1 (es) 1995-06-07
EE9600050A (et) 1996-10-15
BE1007326A3 (fr) 1995-05-16
MA23331A1 (fr) 1995-04-01
IE940838A1 (en) 1995-05-03
NO961429D0 (no) 1996-04-11
AU7997094A (en) 1995-05-08
HU9601041D0 (en) 1996-06-28
SG52202A1 (en) 1998-09-28
CA2174444A1 (fr) 1995-04-27
GR1002181B (en) 1996-03-12
ITMI942130A0 (it) 1994-10-19
IT1270672B (it) 1997-05-07
CH686555A5 (fr) 1996-04-30
ITMI942130A1 (it) 1996-04-19
PL314005A1 (en) 1996-08-05
TNSN94110A1 (fr) 1995-09-21
ATA905894A (de) 2000-06-15
WO1995011022A1 (fr) 1995-04-27

Similar Documents

Publication Publication Date Title
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
TR199802698T2 (xx) Valsartan�n kat� oral doz formlar�.
NO843563L (no) Fremgangsmaate ved fremstilling av farmasoeytiske preparater med hoeyt innhold av aktiv bestanddel som frigjoeres over lengre tid
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
PL340659A1 (en) Spheroides, method of obtaining them and pharmacological compositions
BG103000A (en) Compositions for single daily dosage in the treatment of cyclooxygenase-2-dependent diseases
NO982414L (no) Ny kombinasjon
TW221056B (no)
NZ318282A (en) Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
FR2771292B1 (fr) Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
HUP0105481A2 (hu) Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk
ATE332894T1 (de) Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe
AU583166B2 (en) Oral garlic preparations and process for preparing same
NO961429L (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
BG60101A3 (en) Method for preparing of 4-fluoro-2-[[(4-methoxy-2-pyridinyl)methyl]thionil]-1h-benzimidazo le
AU586410B2 (en) New cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions
CA2063273A1 (en) Surfactant compositions and methods
WO2003045326A3 (en) Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
IL129616A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
CA2294670A1 (en) Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora
IE870577L (en) Topical amide preparation
DK0751940T3 (da) Sesquiterpenderivater
NO972605D0 (no) Ny fremgangsmåte for fremstilling av ranitidin
NO990283L (no) Formulering for behandling og/eller profylakse av demens